Episodes
7
Latest episode
Jul 2024
Language
EN
Welcome to the CLYDE Collision Podcast, where health, technology, policy, equity, and more converge. Hosted by Lisa Josephy, the Managing Director of CLYDE Health, this podcast explores the exciting realms of health and wellness. We'll delve into topics like psychedelics and AI, sharing expert insights, forecasting trends, and examining innovations that will shape the world of health and society. Join us on this journey to navigate the future of healthcare!
Listen in to learn from Dr. Linda Shaprio Manning about the village approach when it comes to treating obesity and how holistic management can set patients up for long term success.
In 2016, Dr. Abid Nazeer founded Hopemark Health as the Midwest's first dedicated outpatient psychiatric-based ketamine clinic. He joined the CLYDE Collision Podcast to talk about how ketamine therapy works, how it's benefiting patients as part of an integrated treatment approach, and the exciting evolution of the mental health treatment landscape.
Words matter. Dr. Linda Shapiro Manning, a physician and advocate with more than 20 years of experience, helped us gain a better understanding of language, its power, and how it can break down--or, unfortunately, reinforce--stigma in the obesity management space.
Elina Onitskansky founded Ilant Health to offer a new approach to obesity management, an industry that has grown rapidly in recent years. What are the long-term implications of this growth? What role should the industry play? What about employers? Elina joined CLYDE Collision to talk about all this and more.
Kathryn Tucker serves as the National Psychedelics Association's Director of Advocacy, and she has seen first-hand how psilocybin and other psychedelics can impact end of life care and mental health. While progress has been made, she joined the CLYDE Collision Podcast to discuss the hurdles still faced by those who need it most.
Steven Huang, Justice, Equity, Diversity and Inclusion Officer at the Multidisciplinary Association for Psychedelic Studies (MAPS), joins the CLYDE Collision Podcast to talk about how the perception of psychedelic therapies by the public has shifted as more and more research comes out, and how we can be prepared for potential pitfalls.
How close are psychedelic therapies to coming to market? What federal and state hurdles still need to be cleared? Karen Luong, a partner at Am Law 100 firm Husch Blackwell and co-founder of its Psychedelics and Emerging Therapies team, joins CLYDE Managing Director Lisa Josephy to break down the current state of play.
Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.
Claim this listing
